Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Korman, Alan"" wg kryterium: Autor


Tytuł :
Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy.
Autorzy :
Tu MM; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Lee FYF; Bristol-Myers Squibb, Lawrenceville, NJ, USA.
Jones RT; Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Kimball AK; Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Saravia E; Bristol-Myers Squibb, Lawrenceville, NJ, USA.
Graziano RF; Bristol-Myers Squibb, Lawrenceville, NJ, USA.
Coleman B; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, USA.
Menard K; Bristol-Myers Squibb, Lawrenceville, NJ, USA.
Yan J; Bristol-Myers Squibb, Lawrenceville, NJ, USA.
Michaud E; Bristol-Myers Squibb, Lawrenceville, NJ, USA.
Chang H; Bristol-Myers Squibb, Lawrenceville, NJ, USA.
Abdel-Hafiz HA; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Rozhok AI; Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, USA.
Duex JE; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Agarwal N; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Chauca-Diaz A; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Johnson LK; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Ng TL; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada.
Cambier JC; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, USA.
Clambey ET; Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Costello JC; Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Korman AJ; Bristol-Myers Squibb, Redwood City, CA, USA.
Theodorescu D; Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA.
Pokaż więcej
Źródło :
Science advances [Sci Adv] 2019 Feb 20; Vol. 5 (2), pp. eaav2437. Date of Electronic Publication: 2019 Feb 20 (Print Publication: 2019).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Delivery Systems*
Immunity, Cellular*
Immunotherapy*
CD8-Positive T-Lymphocytes/*immunology
Dasatinib/*pharmacology
Discoidin Domain Receptor 2/*antagonists & inhibitors
Neoplasms, Experimental/*therapy
Programmed Cell Death 1 Receptor/*antagonists & inhibitors
Animals ; CD8-Positive T-Lymphocytes/pathology ; Cell Line, Tumor ; Discoidin Domain Receptor 2/immunology ; Female ; Mice ; Neoplasms, Experimental/immunology ; Neoplasms, Experimental/pathology ; Programmed Cell Death 1 Receptor/immunology
Czasopismo naukowe
Tytuł :
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy.
Autorzy :
Marciscano AE; Department of Radiation Oncology & Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Ghasemzadeh A; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Nirschl TR; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Theodros D; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Kochel CM; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Francica BJ; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Muroyama Y; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Anders RA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Pathology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Sharabi AB; Department of Radiation Medicine and Applied Sciences, University of California, San Diego, Moores Cancer Center, San Diego, California.
Velarde E; Department of Radiation Oncology & Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Mao W; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Chaudhary KR; Department of Radiation Oncology, Columbia University Medical Center, New York, New York.
Chaimowitz MG; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
Wong J; Department of Radiation Oncology & Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Selby MJ; Bristol-Myers Squibb Company, Redwood City, California.
Thudium KB; Bristol-Myers Squibb Company, Redwood City, California.
Korman AJ; Bristol-Myers Squibb Company, Redwood City, California.
Ulmert D; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Thorek DLJ; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland.
DeWeese TL; Department of Radiation Oncology & Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Drake CG; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. .; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
Pokaż więcej
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Oct 15; Vol. 24 (20), pp. 5058-5071. Date of Electronic Publication: 2018 Jun 13.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunotherapy*/methods
Radiosurgery*/methods
Lymph Nodes/*pathology
Lymph Nodes/*radiation effects
Neoplasms/*pathology
Neoplasms/*therapy
Adoptive Transfer ; Animals ; Cell Line, Tumor ; Combined Modality Therapy ; Cytokines/metabolism ; Disease Models, Animal ; Humans ; Lymph Nodes/immunology ; Lymph Nodes/metabolism ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Lymphocytes, Tumor-Infiltrating/pathology ; Melanoma, Experimental ; Mice ; Neoplasms/immunology ; Neoplasms/metabolism ; Prognosis ; T-Cell Antigen Receptor Specificity ; T-Lymphocyte Subsets/immunology ; T-Lymphocyte Subsets/metabolism ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Effective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model.
Autorzy :
Rakhmilevich AL; Department of Human Oncology, University of Wisconsin, Madison, WI 53705; .; Paul P. Carbone Comprehensive Cancer Center, Madison, WI 53705.
Felder M; Department of Obstetrics and Gynecology, University of Wisconsin, Madison, WI 53705.
Lever L; Department of Human Oncology, University of Wisconsin, Madison, WI 53705.
Slowinski J; Department of Human Oncology, University of Wisconsin, Madison, WI 53705.
Rasmussen K; Department of Human Oncology, University of Wisconsin, Madison, WI 53705.
Hoefges A; Department of Human Oncology, University of Wisconsin, Madison, WI 53705.
Van De Voort TJ; Department of Human Oncology, University of Wisconsin, Madison, WI 53705.
Loibner H; Apeiron Biologics Inc., 1030 Vienna, Austria.
Korman AJ; Bristol-Myers Squibb Company, Redwood City, CA 94063.
Gillies SD; Provenance Biopharmaceuticals, Carlisle, MA 01741; and.
Sondel PM; Department of Human Oncology, University of Wisconsin, Madison, WI 53705.; Paul P. Carbone Comprehensive Cancer Center, Madison, WI 53705.; Department of Pediatrics, University of Wisconsin, Madison, WI 53705.
Pokaż więcej
Źródło :
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2017 Feb 15; Vol. 198 (4), pp. 1575-1584. Date of Electronic Publication: 2017 Jan 06.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Adaptive Immunity*
Immunity, Innate*
Immunotherapy*/methods
Antibodies, Monoclonal/*therapeutic use
Macrophages/*immunology
Melanoma, Experimental/*therapy
Animals ; CD40 Antigens/immunology ; Cytotoxicity, Immunologic ; Immunologic Memory ; Killer Cells, Natural/immunology ; Lymphocyte Activation ; Melanoma, Experimental/immunology ; Mice ; Mice, Inbred C57BL ; Oligodeoxyribonucleotides/immunology ; T-Lymphocytes/immunology
Czasopismo naukowe
Tytuł :
Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.
Autorzy :
Selby MJ; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Engelhardt JJ; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Johnston RJ; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Lu LS; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Han M; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Thudium K; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Yao D; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Quigley M; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Valle J; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Wang C; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Chen B; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Cardarelli PM; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Blanset D; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Korman AJ; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2016 Sep 09; Vol. 11 (9), pp. e0161779. Date of Electronic Publication: 2016 Sep 09 (Print Publication: 2016).
Typ publikacji :
Journal Article
MeSH Terms :
Immunotherapy*
Antibodies, Monoclonal/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Melanoma/*drug therapy
Animals ; Antibodies, Monoclonal/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; CTLA-4 Antigen/antagonists & inhibitors ; CTLA-4 Antigen/metabolism ; Cell Line, Tumor ; Cells, Cultured ; Colorectal Neoplasms/metabolism ; Colorectal Neoplasms/therapy ; Combined Modality Therapy ; Disease Models, Animal ; Female ; Humans ; Ipilimumab ; Lymphocytes/immunology ; Lymphocytes/metabolism ; Macaca fascicularis ; Melanoma/metabolism ; Melanoma/therapy ; Mice ; Mice, Inbred C57BL ; Nivolumab ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/metabolism ; T-Lymphocytes, Regulatory/metabolism
Czasopismo naukowe
Tytuł :
Evolving synergistic combinations of targeted immunotherapies to combat cancer.
Autorzy :
Melero I; Centro de Investigación Médica Aplicada (CIMA) and Clínica Universitaria, Avenida Pío XII, 55 E-31008, Universidad de Navarra, Pamplona, Spain.
Berman DM; Bristol-Myers Squibb, 3551 Lawrenceville Princeton, New Jersey 08648, USA.
Aznar MA; Centro de Investigación Médica Aplicada (CIMA) and Clínica Universitaria, Avenida Pío XII, 55 E-31008, Universidad de Navarra, Pamplona, Spain.
Korman AJ; Bristol-Myers Squibb Biologics Discovery California, 700 Bay Road, Redwood City, California 94063, USA.
Pérez Gracia JL; Centro de Investigación Médica Aplicada (CIMA) and Clínica Universitaria, Avenida Pío XII, 55 E-31008, Universidad de Navarra, Pamplona, Spain.
Haanen J; The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Pokaż więcej
Źródło :
Nature reviews. Cancer [Nat Rev Cancer] 2015 Aug; Vol. 15 (8), pp. 457-72.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Immunotherapy*
Neoplasms/*therapy
Animals ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Biomarkers, Tumor/metabolism ; Clinical Trials as Topic ; Combined Modality Therapy ; Humans ; Molecular Targeted Therapy ; Neoplasms/immunology ; Tumor Microenvironment/immunology
Czasopismo naukowe
Tytuł :
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.
Autorzy :
Gubin MM; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Zhang X; Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Schuster H; Department of Immunology, Institute of Cell Biology, and German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Partner Site Tübingen, Auf der Morgenstelle 15, 72076 Tübingen, Germany.
Caron E; Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland.
Ward JP; 1] Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA [2] Department of Medicine, Division of Oncology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Noguchi T; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Ivanova Y; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Hundal J; The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA.
Arthur CD; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Krebber WJ; ISA Therapeutics B.V., 2333 CH Leiden, The Netherlands.
Mulder GE; ISA Therapeutics B.V., 2333 CH Leiden, The Netherlands.
Toebes M; Division of Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Vesely MD; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Lam SS; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Korman AJ; Bristol-Myers Squibb, 700 Bay Road, Redwood City, California 94063, USA.
Allison JP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Sharpe AH; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Pearce EL; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Schumacher TN; Division of Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Aebersold R; 1] Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland [2] Faculty of Science, University of Zurich, Zurich, 8093 Zurich, Switzerland.
Rammensee HG; Department of Immunology, Institute of Cell Biology, and German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Partner Site Tübingen, Auf der Morgenstelle 15, 72076 Tübingen, Germany.
Melief CJ; 1] ISA Therapeutics B.V., 2333 CH Leiden, The Netherlands [2] Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333ZA Leiden, The Netherlands.
Mardis ER; 1] The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA [2] Department of Genetics, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Gillanders WE; Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Artyomov MN; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Schreiber RD; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Pokaż więcej
Źródło :
Nature [Nature] 2014 Nov 27; Vol. 515 (7528), pp. 577-81.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunotherapy*
Antibodies, Monoclonal/*therapeutic use
Antigens, Neoplasm/*genetics
Antigens, Neoplasm/*immunology
CD8-Positive T-Lymphocytes/*immunology
Cancer Vaccines/*therapeutic use
Cell Cycle Checkpoints/*immunology
Sarcoma/*therapy
Animals ; Epitopes/genetics ; Male ; Mice ; Sarcoma/immunology ; Vaccines, Synthetic/therapeutic use
Czasopismo naukowe
Tytuł :
Workshop on immunotherapy combinations. Society for Immunotherapy of Cancer annual meeting Bethesda, November 3, 2011.
Autorzy :
Martinez Forero I; Centro de Investigacion Medica Aplicada, Universidad de Navarra, Avda Pio XII, 55, 31008 Pamplona, Spain.
Okada H
Topalian SL
Gajewski TF
Korman AJ
Melero I
Pokaż więcej
Źródło :
Journal of translational medicine [J Transl Med] 2012 May 28; Vol. 10, pp. 108. Date of Electronic Publication: 2012 May 28.
Typ publikacji :
Congress
MeSH Terms :
Societies, Medical*
Immunotherapy/*methods
Neoplasms/*immunology
Neoplasms/*therapy
Animals ; Antibodies, Monoclonal/immunology ; Cancer Vaccines/immunology ; Cancer Vaccines/therapeutic use ; Combined Modality Therapy ; Humans ; Immune System/immunology ; Immune System/pathology ; Mice ; Neoplasms/prevention & control
Tytuł :
Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
Autorzy :
Li B; Cell Genesys, Inc., South San Francisco, California 94080, USA.
VanRoey M
Wang C
Chen TH
Korman A
Jooss K
Pokaż więcej
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2009 Mar 01; Vol. 15 (5), pp. 1623-34. Date of Electronic Publication: 2009 Feb 10.
Typ publikacji :
Journal Article
MeSH Terms :
Immunotherapy*
Antibodies, Monoclonal/*therapeutic use
Apoptosis Regulatory Proteins/*antagonists & inhibitors
Colonic Neoplasms/*therapy
Granulocyte-Macrophage Colony-Stimulating Factor/*physiology
Melanoma, Experimental/*therapy
Animals ; Antibodies, Monoclonal/immunology ; Antigens, CD/immunology ; Antigens, CD/metabolism ; Apoptosis Regulatory Proteins/immunology ; Apoptosis Regulatory Proteins/metabolism ; Cell Proliferation ; Colonic Neoplasms/immunology ; Colonic Neoplasms/metabolism ; Cytokines/metabolism ; Drug Synergism ; Enzyme-Linked Immunosorbent Assay ; Lymphocytes, Tumor-Infiltrating/immunology ; Melanoma, Experimental/immunology ; Melanoma, Experimental/metabolism ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Neoplasm Proteins/antagonists & inhibitors ; Neoplasm Proteins/immunology ; Neoplasm Proteins/metabolism ; Programmed Cell Death 1 Receptor ; Rats ; Recombinant Fusion Proteins/immunology ; T-Lymphocytes, Cytotoxic/immunology
Czasopismo naukowe
Tytuł :
Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
Autorzy :
Peggs KS; Howard Hughes Medical Institute, Department of Immunology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
Quezada SA
Korman AJ
Allison JP
Pokaż więcej
Źródło :
Current opinion in immunology [Curr Opin Immunol] 2006 Apr; Vol. 18 (2), pp. 206-13. Date of Electronic Publication: 2006 Feb 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Antibodies, Monoclonal*/immunology
Antibodies, Monoclonal*/pharmacology
Antibodies, Monoclonal*/therapeutic use
Antibodies, Neoplasm*/immunology
Antibodies, Neoplasm*/pharmacology
Antibodies, Neoplasm*/therapeutic use
Antigens, Differentiation/*immunology
Antigens, Neoplasm/*immunology
Immunotherapy/*methods
Neoplasms/*therapy
Animals ; Antigen-Antibody Reactions ; Antigens, CD ; Antigens, Differentiation/drug effects ; Antigens, Neoplasm/drug effects ; CTLA-4 Antigen ; Humans ; Models, Immunological ; Neoplasms/immunology
Czasopismo naukowe
Tytuł :
Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab
Autorzy :
Ramagopal Udupi A.
Liu Weifeng
Garrett-Thomson Sarah C.
Bonanno Jeffrey B.
Yan Qingrong
Srinivasan Mohan
Wong Susan C.
Bell Alasdair
Mankikar Shilpa
Rangan Vangipuram S.
Deshpande Shrikant
Korman Alan J.
Almo Steven C.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America. 114(21):E4223-E4232
Dostęp URL :
https://www.jstor.org/stable/26483333
Czasopismo naukowe
Tytuł :
Immunologic and Clinical Effects of Antibody Blockade of Cytotoxic T Lymphocyte-Associated Antigen 4 in Previously Vaccinated Cancer Patients
Autorzy :
Hodi F. Stephen
Butler Marcus
Oble Darryl A.
Seiden Michael V.
Haluska Frank G.
Kruse Andrea
MacRae Suzanne
Nelson Marybeth
Canning Christine
Lowy Israel
Korman Alan
Lautz David
Russell Sara
Jaklitsch Michael T.
Ramaiya Nikhil
Chen Teresa C.
Neuberg Donna
Allison James P.
Mihm Martin C.
Dranoffa Glenn
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America. 105(8):3005-3010
Dostęp URL :
https://www.jstor.org/stable/25461174
Czasopismo naukowe
Tytuł :
Workshop on immunotherapy combinations. Society for immunotherapy of cancer annual meeting Bethesda, November 3, 2011
Autorzy :
Forero Ivan
Okada Hideho
Topalian Suzanne L
Gajewski Thomas F
Korman Alan J
Melero Ignacio
Pokaż więcej
Temat :
Immunotherapy
Combination immunotherapy
Cancer vaccines
Chemotherapy
Anti-CTLA4
Anti-PD/PD-L1
Medicine
Źródło :
Journal of Translational Medicine, Vol 10, Iss 1, p 108 (2012)
Opis pliku :
electronic resource
Relacje :
http://www.translational-medicine.com/content/10/1/108; https://doaj.org/toc/1479-5876
Dostęp URL :
https://doaj.org/article/fe5b7679619f47b881c2c4913a1a2d01
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies